Yüklüyor......
Immune checkpoint inhibitors in lymphoma: challenges and opportunities
Immune checkpoint inhibitors (ICIs) are immunomodulatory antibodies that intensify the host immune response, thereby leading to cytotoxicity. The primary targets for checkpoint inhibition have included cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), programmed cell death receptor-1 (PD-1) or p...
Kaydedildi:
| Yayımlandı: | Ann Transl Med |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AME Publishing Company
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8267255/ https://ncbi.nlm.nih.gov/pubmed/34277837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-6833 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|